Follistim (TM) (follitropin beta for injection)


Approval Status
Approved September 1997

Treatment for

Diabetes / Endocrinology , Pregnancy & Gynecology

The U.S. Food and Drug Administration approved Oregonon's Follistim (TM) (follitropin beta for injection), the first recombinant follicle-stimulating hormone available in the U.S. for the treatment of infertility. Follistim works by stimulating ovaries to produce one or more eggs during each treatment.

Follistim (TM) (follitropin beta for injection) Drug Information

The Follistim (TM) (follitropin beta for injection) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top